Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2021 | Delix Therapeutics | $70.0M Series A | OMX Ventures, Andrew Levin | Vasudev Bailey, Artis Ventures (AV), B Capital Group, Negev Capital, Prithvi Ventures, PsyMed Ventures, RA Capital, Satori Capital, Trucks Venture Capital, What If Ventures, Apeiron Investment Group, Bail Capital, Casa Verde Capital, Dolby Family Ventures, Noetic Fund, Ocama Partners, Palo Santo, Presight Capital, R^2, re.Mind Capital, Vertical Venture Partners, WPSS |